European Union: Draft Commission Implementing Decision (EU) on the non-approval of terbutryn, 1,2-Benzisothiazol-3(2H)-one (BIT), and tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione (TMAD) as existing active substances
Updated on : 15-03-2026
![European Union: Draft Commission Implementing Decision (EU) on the non-approval of terbutryn, 1,2-Benzisothiazol-3(2H)-one (BIT), and tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione (TMAD) as existing active substances](/images/small//var/www/html/protected/config/../../defaultpic.jpg)
| This draft Commission Implementing Decision does not approve certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council. For these active substance/product-type combinations included in the review programme of existing active substances listed in Annex II to Regulation (EU) No 1062/2014, all the participants have withdrawn or are considered to have withdrawn their support. For these active substances the role of participant had not previously been taken over, but no notification has been submitted to the European Chemicals Agency. Therefore, all these active substance/product-type combinations should not be approved for use in biocidal products. As a consequence, also treated articles treated with or incorporating those active substances cannot be placed on the market in the Union 180 days after the decision. |
Most Recent Announcements
Search All Announcements
National Enquiry Point for Trade
Click here to submit queryWomen Entrepreneurs Networking Platform
Click here to visit WENPMember Area
Search this Site
Contents
Download Trade Portal Apps
Search Trade Information
Import Resources
Feature Information for Entrepreneur
Follow Us
Upcoming Events